Aurinia Pharmaceuticals, Inc (AUPH) Covered Calls

You can sell covered calls on Aurinia Pharmaceuticals, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for AUPH (prices last updated Mon 11:15 AM ET):

Aurinia Pharmaceuticals, Inc (AUPH) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
6.28 +0.01 6.26 6.28 158K - 0.6B
Covered Calls For Aurinia Pharmaceuticals, Inc (AUPH)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Apr 18 7.5 0.10 6.18 1.6% 18.3%
Jul 19 7.5 0.35 5.93 5.9% 17.4%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutic drugs for the treatment of autoimmune diseases in Canada, the United States, China, and Switzerland. The company is developing voclosporin, a calcineurin inhibitor for the treatment of lupus nephritis, dry eye syndrome, and focal segmental glomerulosclerosis. It has a sales agreement with Cantor Fitzgerald & Co.; and a manufacturing collaboration and services agreement with Lonza Ltd. The company was formerly known as Isotechnika Pharma Inc. and changed its name to Aurinia Pharmaceuticals Inc. in October 2013. Aurinia Pharmaceuticals Inc. was founded in 1993 and is headquartered in Victoria, Canada